Skip to Content

Medications for Pneumonia with Cystic Fibrosis

Pneumonia is a potentially serious infection of the lungs caused by bacteria, viruses or rarely fungi. Patients with Cystic fibrosis (an inherited disease that causes thick, sticky mucus to build up in the lungs, and other areas of the body) are prone to developing recurrent chest infections including pneumonia because the mucus in the lungs is thicker and not cleared so easily. This can trap bacteria and lead to infection and inflammation.

Drugs used to treat Pneumonia with Cystic Fibrosis

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
aztreonam Rate Add review
Rx B N

Generic name: aztreonam systemic

Brand name:  Cayston

Drug class: miscellaneous antibiotics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Cayston Rate Add review
Rx B N

Generic name: aztreonam systemic

Drug class: miscellaneous antibiotics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

ceftazidime Rate Add review
Rx B N

Generic name: ceftazidime systemic

Brand names:  Fortaz, Tazicef

Drug class: third generation cephalosporins

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

cilastatin / imipenem Rate Add review
Rx C N

Generic name: cilastatin / imipenem systemic

Brand name:  Primaxin IV

Drug class: carbapenems

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Cipro Rate Add review
Rx C N

Generic name: ciprofloxacin systemic

Drug class: quinolones

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

ciprofloxacin 9.0 1 review
Rx C N

Generic name: ciprofloxacin systemic

Brand names:  Cipro, Cipro I.V., Cipro XR

Drug class: quinolones

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Cipro I.V. Rate Add review
Rx C N

Generic name: ciprofloxacin systemic

Drug class: quinolones

For consumers: dosage, interactions, side effects

Cipro XR Rate Add review
Rx C N

Generic name: ciprofloxacin systemic

Drug class: quinolones

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Fortaz Rate Add review
Rx B N

Generic name: ceftazidime systemic

Drug class: third generation cephalosporins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

piperacillin Rate Add review
Rx B N

Generic name: piperacillin systemic

Drug class: antipseudomonal penicillins

For consumers: dosage, interactions, side effects

Primaxin IV Rate Add review
Rx C N

Generic name: cilastatin / imipenem systemic

Drug class: carbapenems

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Tazicef Rate Add review
Rx B N

Generic name: ceftazidime systemic

Drug class: third generation cephalosporins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription Only.
OTC Over the Counter.
Rx/OTC Prescription or Over the Counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Treatment Options

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.